The anti-tumor efficacy of 20(S)-protopanaxadiol, an active metabolite of ginseng, according to fasting on hepatocellular carcinoma
Open Access
- 1 January 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Ginseng Research
- Vol. 46 (1), 167-174
- https://doi.org/10.1016/j.jgr.2021.06.002
Abstract
No abstract availableKeywords
Funding Information
- Shandong Province Natural Science Foundation
This publication has 24 references indexed in Scilit:
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National LevelJAMA Oncology, 2017
- The biology of Hepatocellular carcinoma: implications for genomic and immune therapiesMolecular Cancer, 2017
- Activation of MMP‐9 by membrane type‐1 MMP/MMP‐2 axis stimulates tumor metastasisCancer Science, 2016
- Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor CytotoxicityCancer Cell, 2016
- A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and HealthspanCell Metabolism, 2015
- Protopanaxadiol, an Active Ginseng Metabolite, Significantly Enhances the Effects of Fluorouracil on Colon CancerNutrients, 2015
- HORMESIS RESULTS IN TRADE-OFFS WITH IMMUNITYEvolution, 2014
- Overexpression of DOC-1R Inhibits Cell Cycle G1/S Transition by Repressing CDK2 Expression and ActivationInternational Journal of Biological Sciences, 2013
- Fasting Enhances the Response of Glioma to Chemo- and RadiotherapyPLOS ONE, 2012
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialThe Lancet Oncology, 2008